Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00800969

Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This prospective study includes patients with histologically proven cancer of the esophagogastric junction (Siewert Type II and III) and the stomach. Aim of the study is to evaluate the accuracy of PET-CT for the preoperative assessment of lymph node metastasis. The evaluation includes a combination with standard diagnostic tools (endoluminal ultrasound, CT and diagnostic laparoscopy prior to neoadjuvant therapy). Standardized D2-lymphadenectomy is performed and individual lymph node stations (Nr 1-12 according to the Japanese classification) are histopathologically examined. Furthermore we evaluate the role of the PET-CT for early metabolic response evaluation in patients receiving neoadjuvant chemotherapy. * Trial with surgical intervention

Conditions

Interventions

TypeNameDescription
PROCEDUREFDG-PET-CTRadiologic standard procedure

Timeline

Start date
2008-10-01
Primary completion
2015-01-01
First posted
2008-12-03
Last updated
2016-06-23

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00800969. Inclusion in this directory is not an endorsement.